| 2025年三季报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 药品(元) | 1,452,931,100.00 | 899,819,754.95 | - | 865,437,045.17 |
| 医疗器械(元) | 527,439,100.00 | 307,040,835.61 | 535,744,231.07 | 212,215,405.49 |
| 片剂(元) | - | - | 1,065,573,584.05 | - |
| 原料药(元) | - | - | 279,763,336.75 | - |
| 针剂(元) | - | - | 86,957,048.37 | - |
| 其他(元) | 102,088,900.00 | 78,481,756.42 | 186,744,043.55 | 48,687,428.33 |
| 营业成本(元) | ||||
| 药品(元) | 793,458,000.00 | 433,628,560.09 | - | 313,357,202.31 |
| 医疗器械(元) | 485,859,100.00 | 284,124,958.71 | 469,276,716.72 | 193,147,826.09 |
| 片剂(元) | - | - | 273,586,275.41 | - |
| 原料药(元) | - | - | 173,875,808.21 | - |
| 针剂(元) | - | - | 27,374,938.68 | - |
| 其他(元) | 84,909,900.00 | 68,860,215.62 | 144,655,049.00 | 45,698,115.27 |
| 毛利(元) | ||||
| 药品(元) | 659,473,100.00 | 466,191,194.86 | - | 552,079,842.86 |
| 医疗器械(元) | 41,580,000.00 | 22,915,876.90 | 66,467,514.35 | 19,067,579.40 |
| 片剂(元) | - | - | 791,987,308.64 | - |
| 原料药(元) | - | - | 105,887,528.54 | - |
| 针剂(元) | - | - | 59,582,109.69 | - |
| 其他(元) | 17,179,000.00 | 9,621,540.80 | 42,088,994.55 | 2,989,313.06 |
| 毛利率(%) | ||||
| 药品(%) | 45.39 | 51.81 | - | 63.79 |
| 医疗器械(%) | 7.88 | 7.46 | 12.41 | 8.99 |
| 片剂(%) | - | - | 74.32 | - |
| 原料药(%) | - | - | 37.85 | - |
| 针剂(%) | - | - | 68.52 | - |
| 其他(%) | 16.83 | 12.26 | 22.54 | 6.14 |
| 收入构成(%) | ||||
| 药品(%) | 69.77 | 70.01 | - | 76.84 |
| 医疗器械(%) | 25.33 | 23.89 | 24.86 | 18.84 |
| 片剂(%) | - | - | 49.45 | - |
| 原料药(%) | - | - | 12.98 | - |
| 针剂(%) | - | - | 4.04 | - |
| 其他(%) | 4.90 | 6.11 | 8.67 | 4.32 |
| 毛利构成(%) | ||||
| 药品(%) | 91.82 | 93.48 | - | 96.16 |
| 医疗器械(%) | 5.79 | 4.59 | 6.24 | 3.32 |
| 片剂(%) | - | - | 74.29 | - |
| 原料药(%) | - | - | 9.93 | - |
| 针剂(%) | - | - | 5.59 | - |
| 其他(%) | 2.39 | 1.93 | 3.95 | 0.52 |